Manufacturer
Taiho Pharmaceutical
- Products listed
- 4
- Molecules
- 3
- Therapy areas
- 1
Taiho Pharmaceutical is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 4 of its products across 3 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Taiho Pharmaceutical CO., LTD., Taiho Pharmaceutical Co., Ltd.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Taiho Pharmaceutical products through licensed channels, with the documents your regulator needs.
Oncology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Inqovi 100 mg/35 mg tabletOral | Cedazuridine and Decitabine | US FDA | Available on request |
| Lonsurf 6.14 mg/15 mg tabletOral | Tipiracil and Trifluridine | US FDA | Available on request |
| Lonsurf 8.19 mg/20 mg tabletOral | Tipiracil and Trifluridine | US FDA | Available on request |
| Lytgobi 4 mg tabletOral | Futibatinib | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Taiho Pharmaceutical
Send a request for any of these products. We confirm the licensed source, documents and lead time.